<?xml version="1.0" encoding="UTF-8"?>
<p>This study marks a significant step forward in raising the visibility of the HIV epidemic among transgender women in sub-Saharan Africa. However, the findings may not be generalizable to other transgender women in the region due to the use of sampling strategies tailored for cis-MSM. While studies in other regions that specifically recruited transgender women consistently demonstrated a high prevalence of HIV in this population [
 <xref rid="pmed.1002422.ref012" ref-type="bibr">12</xref>], emerging transgender-specific data support associations between access to gender affirmation and HIV risk [
 <xref rid="pmed.1002422.ref051" ref-type="bibr">51</xref>], and it remains a testable hypothesis that transgender women with early access to legal, medical, social, and psychological gender affirmation may be less likely to participate in cis-MSM social networks and also less likely to experience psychosocial drivers of HIV infection.
</p>
